CIK 0001287098 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522210438
- Phone
- 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 42 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-09 | Johnston John Joseph Director | Option exercise 10b5-1 | +891 | $2.93 | $3K | 142,841 |
| 2024-12-09 | Johnston John Joseph Director | Option exercise 10b5-1 | +1,121 | $1.64 | $2K | 143,962 |
| 2024-12-09 | Johnston John Joseph Director | Option exercise 10b5-1 | +483 | $2.93 | $1K | 144,445 |
| 2024-12-09 | Johnston John Joseph Director | Sale 10b5-1 | −2,495 | $3.79 | $9K | 141,950 |
| 2024-12-09 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −891 | 0 | ||
| 2024-12-09 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −1,121 | 0 | ||
| 2024-12-09 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −483 | 23,417 | ||
| 2024-12-06 | Johnston John Joseph Director | Option exercise 10b5-1 | +505 | $2.93 | $1K | 142,455 |
| 2024-12-06 | Johnston John Joseph Director | Sale 10b5-1 | −505 | $3.70 | $2K | 141,950 |
| 2024-12-06 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −505 | 891 | ||
| 2024-11-01 | Erck Stanley C Director | Option exercise 10b5-1 | +47,689 | $0.04 | $2K | 316,807 |
| 2024-11-01 | Erck Stanley C Director | Sale 10b5-1 | −47,689 | $3.72 | $177K | 269,118 |
| 2024-11-01 | Erck Stanley C Director | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −47,689 | 0 | ||
| 2024-10-28 | Johnston John Joseph Director | Option exercise 10b5-1 | +3,000 | $2.93 | $9K | 144,950 |
| 2024-10-28 | Johnston John Joseph Director | Sale 10b5-1 | −3,000 | $3.72 | $11K | 141,950 |
| 2024-10-28 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 1,396 | ||
| 2024-10-14 | Collins Cynthia Director | Grant or award | +51,679 | 51,679 | ||
| 2024-10-14 | Collins Cynthia Director | Grant or award · Stock Option (right to buy) | +97,698 | 97,698 | ||
| 2024-10-02 | Erck Stanley C Director | Option exercise 10b5-1 | +21,607 | $0.04 | $864 | 290,725 |
| 2024-10-02 | Erck Stanley C Director | Sale 10b5-1 | −21,607 | $3.71 | $80K | 269,118 |
Page 4 of 15 · 282 trades